Keyphrases
Cell Proliferation
100%
Antibody Productivity
100%
Perfusion Culture
100%
B-cell Lymphoma 2 (Bcl-2)
66%
High Cell Density
66%
Antibody Production
66%
Cell Viability
66%
Biopharmaceuticals
33%
Apoptosis
33%
G1 Phase
33%
Overexpression
33%
Overexpressing
33%
High Density
33%
Fold Increase
33%
4-fold
33%
IgG4 Antibodies
33%
Cyclin-dependent Kinase Inhibitor
33%
Myeloma Cells
33%
Bcl-2 Expression
33%
Anti-apoptotic Proteins
33%
Increased Productivity
33%
Mammalian Cell Culture
33%
Multigenic
33%
Continuous Perfusion
33%
Industrial Production
33%
Culture Results
33%
High Productivity
33%
Low Cell numbers
33%
Low Culture
33%
Biochemistry, Genetics and Molecular Biology
P21
100%
Cell Cycle
100%
Cell Density
100%
Bcl-2
100%
Cell Proliferation
100%
Perfusion
100%
Antibody Production
66%
Cell Viability
66%
G1 Phase
33%
Cyclin-Dependent Kinase
33%
Cell Culture
33%
Programmed Cell Death
33%
Immunology and Microbiology
Bcl-2
100%
Cell Density
100%
Cell Proliferation
100%
Cell Cycle
100%
Perfusion
100%
Cell Viability
66%
Antibody Generation
66%
Cell Culture
33%
Immunoglobulin G4
33%
Myeloma Cell Line
33%
Cycline
33%
Cell Antibody
33%
Cell Cycle G1 Phase
33%
Programmed Cell Death
33%
Neuroscience
Bcl-2
100%
Cell Density
100%
Cell Proliferation
100%
Cell Cycle
100%
Cell Viability
66%
Antibody Production
66%
Cell Line
33%
Cell Culture
33%
Cyclin-Dependent Kinase
33%
Immunoglobulin G4
33%
Cell Cycle G1 Phase
33%
Cyclin Dependent Kinase Inhibitor 1
33%
Cell Antibody
33%
Programmed Cell Death
33%
Engineering
Perfusion Culture
100%
Dependent Kinase Inhibitor
50%
Fold Increase
50%
Overexpression
50%
Industrial Production
50%